Qatar Pharmaceutical Warehousing Market-Size, Competition and Forecast Analysis and Forecast (2018-2028)

Qatar Pharmaceutical Warehousing Market-Size, Competition and Forecast Analysis and Forecast (2018-2028)

Executive Summary

The pharmaceutical logistics and warehousing sector in Qatar is characterized by a meticulously regulated and well-organized system that ensures the secure and efficient distribution of pharmaceutical products within the country. While Qatar does import a substantial portion of its pharmaceuticals, there is a growing emphasis on the local manufacturing of pharmaceuticals. The Qatari government has taken proactive measures to encourage domestic production, particularly of essential medications.

Abdulaziz Bin Hamad Al Aqeel, Secretary-General of the Gulf Organisation, estimates that the GCC (Gulf Cooperation Council) imports approximately 90% of its medications. This presents a significant opportunity for reducing reliance on foreign drug imports and paves the way for local manufacturers to seize the immense potential in the market.

The COVID-19 pandemic has heightened the importance of the pharmaceutical industry. In 2022, Qatar Airways Cargo facilitated the transportation of over 84,000 tonnes of medical and healthcare shipments worldwide through its global network, with Doha and regional hubs in Europe playing pivotal roles.

Qatar boasts a few pharmacy chains that play a critical role in pharmaceutical distribution. These chains maintain a network of outlets throughout the country, ensuring easy access to medications for the population. To address the expanding logistics needs of Qatar, Nasser Bin Khaled International, a division of Nasser Bin Khaled and Sons, signed a Memorandum of Understanding (MOU) with Germany's Ehrhardt + Partner Group (EPG) in 2023 for the establishment of a cutting-edge fully automated mega logistics park with an investment of USD 500 million.

Given the sensitivity of numerous pharmaceutical products to temperature fluctuations, cold chain logistics also play a pivotal role. Qatar-based maritime and logistics company Milaha has inaugurated Phase 1 of the Milaha Logistics City, spanning 400,000 sqm and featuring a 35,000 sqm temperature-controlled cargo storage facility. Milaha's new facility will provide essential cold chain solutions for the food industry, pharmaceuticals, and other fast-moving consumer goods (FMCG).

Major Importer of Pharmaceutical Products

Due to the absence of many indigenous pharmaceutical companies in the area, the pharmaceutical market in Qatar is currently heavily skewed towards export products. Several international corporations, including Roche, Merck, GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, and others, export pharmaceutical products to the region. The fact that there are significant pharmaceutical conglomerates in the area explains why the US is the region's top importer into the Qatari market. In addition, other nations such as Germany, India, the UK, Italy, the UAE, and others import pharmaceuticals to the Qatari market.

Exports of Pharmaceutical Products

Only reputable pharmaceutical firms in Qatar export over-the-counter (OTC) goods, nutraceutical drugs, and other pharma items that come in a variety of dosage forms. Tablets, injections, ointments, drops, syrups, sachets, and other medicinal goods are frequently found in Qatar.

Rising Demand of Cold storage

To keep the supply and demand in balance, there will always be a need for industrial refrigeration. Due to the expanding market share of health insurance providers and the rising incidence of non-communicable diseases, the demand for medicines in Qatar is increasing significantly.

Market Performance & Future Outlook

The market exhibited a positive growth trend, although there was not a substantial increase in revenue. The primary driver behind this growth can be attributed to the introduction of GWC's new warehousing facility in 2022. In addition to this, GAC Qatar collaborated with the Qatar Free Zones Authority (QFZA) to inaugurate a sustainable 27,000 m2 multi-user contract logistics facility and office building in Ras Bufontas Free Zone. This state-of-the-art facility boasts up to 40,000 pallet positions and is equipped with four temperature and humidity-controlled chambers, making it well-suited to cater to a diverse range of industries including but not limited to food and beverages, fast-moving consumer goods, retail, and telecommunications.

The pharmaceutical sector in Qatar is anticipated to experience ongoing expansion, with a strong focus on fostering innovation, research, and development. Furthermore, there is an increasing emphasis on incorporating sustainability and environmental considerations into pharmaceutical logistics practices. The pharmaceutical industry is on the brink of significant growth in the upcoming years, fueled by the expansion of the middle-class demographic and the aging global population.

Considering the pharmaceutical market's projected growth of 165.2% from 2020 to 2030, this industry presents highly attractive opportunities for potential investors and stakeholders interested in investing in warehouse infrastructure. As a result, the pharmaceutical logistics and warehouse market is poised for substantial expansion, with a projected Compound Annual Growth Rate (CAGR) of 6.9%.

Scope of the Study

Makreo Research conducted an in-depth study titled "Analysis and Forecast of the Pharmaceutical Logistics and Warehousing Market in Qatar (2018-2030)," offering a comprehensive examination of various market aspects. This report employs a holistic approach by considering both qualitative and quantitative factors, ensuring a well-rounded analysis. By incorporating both these dimensions, the study provides readers with a more comprehensive grasp of the Qatar Pharmaceutical Logistics & Warehousing Market. It goes beyond mere numerical data and delves into insights about consumer behavior, industry trends, and market dynamics. This all-encompassing approach enriches the overall analysis, rendering the study a valuable resource for individuals or organizations seeking to explore the pharmaceutical, logistics, warehousing, and cold chain market in Qatar.

Furthermore, the report focuses on evaluating historical and current performance while also identifying potential growth opportunities in the future. This enables readers to pinpoint key areas of interest and investment.

The assessment of the pharmaceutical logistics and warehousing market in Qatar entails an examination of market revenue, future prospects, and emerging opportunities.

Competitive Landscape Includes:

• Competitive Landscape
• Mergers/Acquisition/Investment
• Company Profiles

Key Questions Answered

1. What has been the historical performance of the pharmaceutical industry in Qatar, and what can be expected in terms of future growth?

2. How has the logistics and warehousing industry in Qatar fared in the past, and what is the current landscape?

3. What is the status of the pharmaceutical industry in Qatar in the aftermath of the pandemic?

4. What are the primary factors driving growth within the industry?

5. How is the demand shaping up for logistics and warehousing service providers in Qatar?

6. How has the supply chain in Qatar evolved in the year 2023?

7. What is the current performance of the Cold Chain market?

8. What are the major challenges confronting the Cold Chain market?

9. Who are the key players in the market, and what is their current performance status?

10. What noteworthy achievements and highlights can be attributed to these market players?

11. What is the current financial standing of these players?

12. What is the prevailing investment landscape?

13. What significant merger and acquisition activities have taken place in the industry?